Results 31 to 40 of about 6,111 (249)

Rethinking pityriasis rubra pilaris as a paraneoplastic syndrome: Two cases of pityriasis rubra pilaris with concomitant underlying malignancy [PDF]

JAAD Case Reports, 2023
Anna E. Davis, BS, Brielle E. Raine, BS, Isaac Swartzman, BS, Paul N. Bogner, MD, Michael Nazareth, MD, PhD   +4 more
doaj   +2 more sources

Pityriasis Rubra Pilaris Following COVID-19 Infection: A Case of Successful Treatment With Ixekizumab. [PDF]

Cureus
Pityriasis rubra pilaris (PRP) is a rare dermatologic disorder marked by erythema, scaling, pruritus, pain, and follicular hyperkeratosis. It usually appears as red, scaly patches with areas of unaffected skin and is commonly associated with orange ...
Ross MN, Snider WT, Depew I, Cook S.
europepmc   +2 more sources

Updates on Pityriasis Rubra Pilaris: A Scoping Review. [PDF]

J Cutan Med Surg
Pityriasis rubra pilaris (PRP) is a rare, inflammatory papulosquamous skin disease with unknown exact etiology. Historically, PRP has been challenging to diagnose, especially during the acute phase, and to treat, due to its unclear pathogenesis.
Zhou T, Al Muqrin A, Abu-Hilal M.
europepmc   +2 more sources

The Effectiveness of Anti-Interleukin-17A Treatment for Pityriasis Rubra Pilaris: A Systematic Review. [PDF]

Cureus, 2023
Abduljawad M, Alsharif TH, Gronfula AG, Magadmi TK, Khayat LI, Fageeh SM, Almuallim AA, Mohammad MA, Albadri A.   +8 more
europepmc   +3 more sources

Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children. [PDF]

Dermatol Ther (Heidelb), 2023
Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that affects men and women of all ages, including children. PRP is characterized by follicular and palmoplantar hyperkeratosis and salmon-colored scaling plaques.
Kołt-Kamińska M, Osińska A, Kaznowska E, Reich A.   +3 more
europepmc   +2 more sources

Pityriasis Rubra Pilaris In The Indian Scenario

Indian Journal of Dermatology, 2002
Pityriasis rubra pilaris (PRP) is an uncommon idiopathic papulosqamous disorder characterized by circumscribed follicular keratosis, palmoplantar keratoderma and frequently erythroderma. Seven patients of PRP (five females and two males) in the age range
Sarkar Rashmi, Bhalla Mala, Kaur Charandeep, Kanwar A.J   +3 more
doaj   +1 more source

Pityriasis Rubra Pilar and hypothyroidism [PDF]

Anais Brasileiros de Dermatologia, 2014
Pityriasis Rubra Pilaris (PRP) is a chronic and rare papulosquamous disorder. Treatment of Pityriasis Rubra Pilaris is based on empiric evidence because of several doubts regarding its etiology and also because of its relative rarity, making randomized ...
Aline Martinez Franzotti, Juliana Centofanti Dentello Avelar, Thaís Abrão Cardoso, Mario Cesar Pires, Maria do Rosário Vidigal   +4 more
doaj   +2 more sources

Bimekizumab in refractory pityriasis rubra pilaris [PDF]

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023
Christian Kromer, Michael P. Schön, Rotraut Mößner   +2 more
openalex   +2 more sources

Delayed Presentation of Pityriasis Rubra Pilaris in a Patient on Treatment With Ponatinib. [PDF]

Cureus
Pityriasis rubra pilaris (PRP) is a rare dermatologic condition whose etiology is largely unknown. However, some medications, including ponatinib, have been implicated. Our case features an 80-year-old patient who developed PRP after two-and-a-half years
Yaldo MM, Olds H, Hengy M, Moossavi M.
europepmc   +2 more sources

Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris. [PDF]

Life (Basel)
Pityriasis rubra pilaris (PRP) is a rare, papulosquamous, inflammatory skin disease. PRP represents a therapeutic challenge. The rarity of this disease and its possible spontaneous remission makes the conduction and interpretation of therapeutic studies ...
Potestio L, D'Agostino M, Portarapillo A, Esposito V, Tommasino N, Salsano A, Guerriero L, Martora F, Megna M.   +8 more
europepmc   +2 more sources